Harold W Davis Selected Research

Saposins

5/2022	Phosphatidylserine: The Unique Dual-Role Biomarker for Cancer Imaging and Therapy.
11/2021	SapC-DOPS as a Novel Therapeutic and Diagnostic Agent for Glioblastoma Therapy and Detection: Alternative to Old Drugs and Agents.
6/2021	Targeting of elevated cell surface phosphatidylserine with saposin C-dioleoylphosphatidylserine nanodrug as individual or combination therapy for pancreatic cancer.
5/2020	Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher disease.
1/2020	Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer.
1/2020	Biotherapy of Brain Tumors with Phosphatidylserine-Targeted Radioiodinated SapC-DOPS Nanovesicles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Harold W Davis Research Topics

Disease

8	Neoplasms (Cancer) 05/2022 - 05/2005
4	Insulin Resistance 06/2016 - 09/2012
2	Brain Neoplasms (Brain Tumor) 11/2021 - 01/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 06/2021 - 01/2020
1	Carcinogenesis 05/2022
1	Glioblastoma (Glioblastoma Multiforme) 11/2021
1	Gaucher Disease (Gaucher's Disease) 05/2020
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 05/2020
1	Adenocarcinoma 01/2020
1	Glucose Intolerance 06/2016
1	Starvation 06/2013
1	Hypoglycemia (Reactive Hypoglycemia) 01/2012
1	Body Weight (Weight, Body) 01/2012
1	Fistula 03/2010
1	Necrosis 05/2005
1	Vascular System Injuries 05/2005
1	Ischemia 01/2005

Drug/Important Bio-Agent (IBA)

6	SaposinsIBA 05/2022 - 01/2020
6	PhosphatidylserinesIBA 05/2022 - 10/2016
5	GhrelinIBA 06/2016 - 03/2010
4	Pharmaceutical PreparationsIBA 11/2021 - 01/2019
4	Glucose (Dextrose)FDA LinkGeneric 07/2014 - 01/2012
2	Proteins (Proteins, Gene)FDA Link 11/2021 - 05/2005
2	Insulin (Novolin)FDA Link 07/2014 - 09/2012
2	Protein Isoforms (Isoforms)IBA 09/2012 - 01/2005
1	Monoclonal AntibodiesIBA 05/2022
1	CalciumIBA 05/2022
1	bavituximabIBA 05/2022
1	Biomarkers (Surrogate Marker)IBA 05/2022
1	Liposomes (Liposome)IBA 11/2021
1	Temozolomide (Temodar)FDA LinkGeneric 11/2021
1	LipidsIBA 11/2021
1	Tumor Biomarkers (Tumor Markers)IBA 06/2021
1	GlucosidasesIBA 05/2020
1	AcidsIBA 05/2020
1	EnzymesIBA 05/2020
1	Albumin-Bound Paclitaxel FDA Link 01/2020
1	Gemcitabine FDA Link 01/2020
1	Fluorescent Dyes (Fluorescent Probes)IBA 10/2016
1	Indicators and Reagents (Reagents)IBA 10/2016
1	Coloring Agents (Dyes)IBA 10/2016
1	Glucagon-Like Peptide 1 (GLP 1)IBA 06/2016
1	Growth Hormone (Somatotropin)IBA 09/2012
1	Ghrelin ReceptorsIBA 01/2012
1	AcyltransferasesIBA 01/2012
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2012
1	CytokinesIBA 05/2005
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2005
1	Protein Kinase C-epsilonIBA 01/2005

Therapy/Procedure

5	Therapeutics 05/2022 - 01/2019
1	Radiotherapy 11/2021
1	Drug Therapy (Chemotherapy) 11/2021
1	Enzyme Replacement Therapy 05/2020
1	Biological Therapy 01/2020